Premature Babies Study Raises Debate Over Risks and Ethical Consent

Two years ago, researchers in a clinical trial involving oxygen levels for the tiniest premature babies were accused by a federal watchdog agency of not properly disclosing the risks to families who participated.

What followed was extensive public scrutiny of the trial, called Support, and soul-searching in the research community about how best to obtain informed consent from participants. Some families sued, arguing that their babies suffered serious injuries as a result of their treatment.

Full coverage from the New York Times available here.